HAWAII LUNG CANCER SUMMIT
July 6 - 10, 2022
OVERVIEW
FOCUSING ON:
APPROVED AND EMERGING TYROSINE KINASE INHIBITORS AND
OTHER TARGETED AGENTS
IMMUNOTHERAPY AND IMMUNE CHECKPOINT INHIBITORS
SMALL CELL LUNG CANCER AND MESOTHELIOMA
EMERGING ANTIBODY-DRUG CONJUGATES, ANTIBODIES, AND CAR-T THERAPY
FEATURING 100 ATTENDEES, 80 LECTURES
60 KOLS, 20+ EMERGING AGENT
Venue: FEATURING 100 ATTENDEES, 80 LECTURES
60 KOLS, 20+ EMERGING AGENT